Rucaparib in recurrent ovarian cancer: real-world experience from the rucaparib early access programme in Spain - A GEICO study.
Saved in:
| Title: | Rucaparib in recurrent ovarian cancer: real-world experience from the rucaparib early access programme in Spain - A GEICO study. |
|---|---|
| Authors: | Yubero, Alfonso1 (AUTHOR) ayuberoe@salud.aragon.es, Barquín, Aranzazu2 (AUTHOR), Estévez, Purificación3 (AUTHOR), Pajares, Bella4 (AUTHOR), Sánchez, Luisa5 (AUTHOR), Reche, Piedad6 (AUTHOR), Alarcón, Jesús7 (AUTHOR), Calzas, Julia8 (AUTHOR), Gaba, Lydia9 (AUTHOR), Fuentes, José10 (AUTHOR), Santaballa, Ana11 (AUTHOR), Salvador, Carmen12 (AUTHOR), Manso, Luis13 (AUTHOR), Herrero, Ana14 (AUTHOR), Taus, Álvaro15 (AUTHOR), Márquez, Raúl16 (AUTHOR), Madani, Julia17 (AUTHOR), Merino, María18 (AUTHOR), Marquina, Gloria19 (AUTHOR), Casado, Victoria20 (AUTHOR) |
| Source: | BMC Cancer. 11/8/2022, Vol. 22 Issue 1, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
